Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs02984679

Ligand	Ligand name	Chain	PDB	Tanimoto
RS3	1-deoxy-1-[8-(dimethylamino)-7-methyl-2,4-dioxo-3,4-dihydrobenzo[g]pteridin-10(2H)-yl]-D-ribitol	X,Y	3F4H	0.72
RBF	RIBOFLAVINE	B,D,F,H	2FL5	0.72
RBF	RIBOFLAVINE	A	2CC8	0.72
RBF	RIBOFLAVINE	A,B	1PKV	0.72
RBF	RIBOFLAVINE	A,B	1T6Z	0.72
RBF	RIBOFLAVINE	A	2VX9	0.72
RBF	RIBOFLAVINE	A,B,C,D,E	1KYV	0.72
RBF	RIBOFLAVINE	A	1MOG	0.72
RBF	RIBOFLAVINE	A,B,C,D,E,F,G,H,I,J,K,L	2VXA	0.72
RBF	RIBOFLAVINE	A,B	1L5R	0.72
RBF	RIBOFLAVINE	A,B	1HZE	0.72
RBF	RIBOFLAVINE	A,B,C,D,E	2A58	0.72
RBF	RIBOFLAVINE	A,B	1BU5	0.72
RBF	RIBOFLAVINE	X,Y	3F4G	0.72
RBF	RIBOFLAVINE	A	1NB9	0.72
RBF	RIBOFLAVINE	A,B	1I18	0.72
RBF	RIBOFLAVINE	A	3DDY	0.72
RBF	RIBOFLAVINE	A	2CCB	0.72
GEP	N-METHYL-N-(PARA-GLUTARAMIDOPHENYL-ETHYL)-PIPERIDINIUM ION	L	25C8	0.72
SPB	4-(4-STYRYL-PHENYLCARBAMOYL)-BUTYRIC ACID	B,H	1UB5	0.7
SPB	4-(4-STYRYL-PHENYLCARBAMOYL)-BUTYRIC ACID	A,B,H,L	3CFB	0.7
SPB	4-(4-STYRYL-PHENYLCARBAMOYL)-BUTYRIC ACID	B,H	3CFD	0.7
SPB	4-(4-STYRYL-PHENYLCARBAMOYL)-BUTYRIC ACID	A,L	1FL3	0.7
CF4	[4-(7,8-dimethyl-2,4-dioxo-3,4-dihydrobenzo[g]pteridin-10(2H)-yl)butyl]carbamic acid	A	2VKG	0.7
MNI	N-{[(2R,3R,4R,5R)-3,4-DIHYDROXY-5-(HYDROXYMETHYL)PYRROLIDIN-2-YL]METHYL}-4-(DIMETHYLAMINO)BENZAMIDE	A,B	2OYM	0.7
VG7	N-[(1S,2R)-1-benzyl-3-(cyclohexylamino)-2-hydroxypropyl]-3-(ethylamino)-5-(2-oxopyrrolidin-1-yl)benzamide	A	2VJ9	0.71
BEP	1-ISOBUTOXY-2-PYRROLIDINO-3[N-BENZYLANILINO] PROPANE	C	1LXF	0.71
BEP	1-ISOBUTOXY-2-PYRROLIDINO-3[N-BENZYLANILINO] PROPANE	A	1DTL	0.71
THF	5-HYDROXYMETHYLENE-6-HYDROFOLIC ACID	A,B,C,D	1EJI	0.7
THF	5-HYDROXYMETHYLENE-6-HYDROFOLIC ACID	A	1U3G	0.7
THF	5-HYDROXYMETHYLENE-6-HYDROFOLIC ACID	A	2TDD	0.7
009	(4S)-1,4-dibenzyl-N-[(1S,2R)-1-benzyl-3-{[3-(dimethylamino)benzyl]amino}-2-hydroxypropyl]-2-oxoimidazolidine-4-carboxamide	A,B,C	3CKR	0.7
GA0	GLYCYLALANYL-N-2-NAPHTHYL-L-PROLINEAMIDE	A	2DCM	0.73
SN8	1,6-DIMETHYL-4-(4-(4-(1-METHYLPYRIDINIUM-4-YLAMINO)PHENYLCARBAMOYL)PHENYLAMINO)QUINOLINIUM	A,B	1ZPH	0.7
IRF	1-DEOXY-1-(8-IODO-7-METHYL-2,4-DIOXO-3,4-DIHYDROBENZO[G]PTERIDIN-10(2H)-YL)-D-RIBITOL	A	2J08	0.72
SLD	(3Z)-N-[(4E)-5-(4-{(5S)-5-[(acetylamino)methyl]-2-oxo-1,3-oxazolidin-3-yl}-2-fluorophenyl)pent-4-en-1-yl]-3-(4-methyl-2,6-dioxo-1,6-dihydropyrimidin-5(2H)-ylidene)propanamide	0,2,4,9,A,B,C,H,I,J,K,L,M,N,P,Q,R,S,T,X,Y,Z	3CXC	0.76
VPU	[[(3R,4R,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-(pentanoylamino)oxan-2-ylidene]amino] N-phenylcarbamate	A	3GSM	0.7
45U	(S)-N-(4-carbamimidoylbenzyl)-1-(2-(cyclopentyloxy)ethanoyl)pyrrolidine-2-carboxamide	A	2ZDL	0.71
45U	(S)-N-(4-carbamimidoylbenzyl)-1-(2-(cyclopentyloxy)ethanoyl)pyrrolidine-2-carboxamide	H,I	2ZFQ	0.71
FFO	5-FORMYL-6-HYDROFOLIC ACID	A,B,C,D	1EQB	0.7
FFO	5-FORMYL-6-HYDROFOLIC ACID	A	1JOM	0.7
FFO	5-FORMYL-6-HYDROFOLIC ACID	A	1PJ7	0.7
FFO	5-FORMYL-6-HYDROFOLIC ACID	A,B,C,D	1DFO	0.7
FFO	5-FORMYL-6-HYDROFOLIC ACID	A,B	2VMY	0.7
FFO	5-FORMYL-6-HYDROFOLIC ACID	A,B	1JOL	0.7
FFO	5-FORMYL-6-HYDROFOLIC ACID	A	1WOP	0.7
46U	(S)-N-(4-carbamimidoylbenzyl)-1-(2-(cyclohexyloxy)ethanoyl)pyrrolidine-2-carboxamide	H,I	2ZFR	0.72
46U	(S)-N-(4-carbamimidoylbenzyl)-1-(2-(cyclohexyloxy)ethanoyl)pyrrolidine-2-carboxamide	A	2ZDM	0.72